Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 8:17pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
Enter symbol(s):
Market:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
|
Alphabetical List
Gilead Sciences Inc. (GILD)
At 5:00AM SGT:
46.30 USD
0.00 (0.00%)
MORE ON GILD
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Gilead Sciences, Inc.
(NasdaqNM:GILD) Delayed quote data
Last Trade:
46.30 USD
Trade Time:
5:00AM SGT
Change:
0.00 (0.00%)
Prev Close:
46.30
Open:
N/A
Bid:
45.86
x 200
Ask:
48.96
x 100
1y Target Est:
54.57
Day's Range:
N/A - N/A
52wk Range:
40.62 - 51.85
Volume:
0
Avg Vol
(3m)
:
8,522,300
Market Cap:
41.66B
P/E
(ttm)
:
17.90
EPS
(ttm)
:
2.59
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Use Y! Toolbar to track stocks
Add GILD to Portfolio
Download Data
HEADLINES
Now's the Time to Invest in These Stocks
at Motley Fool
(Wed 8:00pm)
Cramer's Lightning Round - I Like Nike (2/8/10)
at Seeking Alpha
(Tue 5:49pm)
Lightning Round: Nike, Visa, Gilead Science and More
at CNBC
(Tue 12:28pm)
'Mad Money Lightning Round': Visa Rocks
at TheStreet.com
(Tue 8:33am)
Cramer's 'Mad Money' Recap: The Lure of Semiconductor Stocks (Final)
at TheStreet.com
(Tue 8:24am)
[video] Options Action
at CNBC
(Tue 6:34am)
[$$] Biotech ETFs Are Looking Healthy
at RealMoney by TheStreet.com
(Tue 5:50am)
Director William Furman Buys $2.1M Worth of Schnitzer Steel
TheStreet.com
(Mon, Feb 8)
4 Winning Biotechs For Your Portfolio: Senior Analyst
at CNBC
(Mon, Feb 8)
Traders Send Select Stem Cell Shares Soaring
Indie Research
(Mon, Feb 8)
Is Biotech Back?
CNBC
(Mon, Feb 8)
[video] Is Biotech Back?
at CNBC
(Mon, Feb 8)
More Headlines for GILD...
ANALYST
EPS Est (next year)
(Dec-09)
:
2.77
EPS Est (in 2 years)
(Dec-10)
:
3.11
Avg Rec (current)*:
1.9
PEG Ratio:
1.13
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life-threatening infectious diseases.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
Latest News
Singapore Indices